Functional Roles of DYRK2 as a Tumor Regulator

被引:3
作者
Mochimaru, Yuta [1 ]
Yoshida, Kiyotsugu [1 ]
机构
[1] Jikei Univ, Sch Med, Dept Biochem, Tokyo 1058461, Japan
关键词
DYRK2; solid tumor; non-solid tumor; EPITHELIAL-MESENCHYMAL-TRANSITION; PLURIPOTENT STEM-CELLS; BREAST-CANCER; DOWN-REGULATION; EMERGING ROLE; KINASE; EXPRESSION; GENE; SPECIFICITY; SUPPRESSOR;
D O I
10.3390/cimb45100538
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The dual-specificity tyrosine phosphorylation-regulated kinase 2 (DYRK2) regulates the induction of apoptosis and DNA repair, metastasis inhibition, cell cycle G1/S transition, protein scaffold stability for E3 ligase complexes, and embryogenesis. Owing to these functions, DYRK2 is thought to regulate tumorigenesis, and its function in cancer has been investigated. Notably, DYRK2 has been reported to function as a tumor suppressor; however, it has also been reported to act as an oncogene in some cancers. This discrepancy makes it difficult to elucidate the conserved functions of DYRK2 in cancer. Here, we reviewed the functions of DYRK2 in various cancers. Patient tissue samples were evaluated for each cancer type. Although some studies have used cell lines and/or xenografts to elucidate the mechanism of DYRK2 function, these studies are not sufficient to understand the role of DYRK2 in cancers. In particular, studies using genetically modified mice would help us to understand the reported functional duality of DYRK2 in cancer.
引用
收藏
页码:8539 / 8551
页数:13
相关论文
共 55 条
  • [1] Inhibition of dual-specificity tyrosine phosphorylation-regulated kinase 2 perturbs 26S proteasome-addicted neoplastic progression
    Banerjee, Sourav
    Wei, Tiantian
    Wang, Jue
    Lee, Jenna J.
    Gutierrez, Haydee L.
    Chapman, Owen
    Wiley, Sandra E.
    Mayfield, Joshua E.
    Tandon, Vasudha
    Juarez, Edwin F.
    Chavez, Lukas
    Liang, Ruqi
    Sah, Robert L.
    Costello, Caitlin
    Mesirov, Jill P.
    de la Vega, Laureano
    Cooper, Kimberly L.
    Dixon, Jack E.
    Xiao, Junyu
    Lei, Xiaoguang
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (49) : 24881 - 24891
  • [2] Ancient drug curcumin impedes 26S proteasome activity by direct inhibition of dual-specificity tyrosine-regulated kinase 2
    Banerjee, Sourav
    Ji, Chenggong
    Mayfield, Joshua E.
    Goel, Apollina
    Xiao, Junyu
    Dixon, Jack E.
    Guo, Xing
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2018, 115 (32) : 8155 - 8160
  • [3] Sequence characteristics, subcellular localization, and substrate specificity of DYRK-related kinases, a novel family of dual specificity protein kinases
    Becker, W
    Weber, Y
    Wetzel, K
    Eirmbter, K
    Tejedor, FJ
    Joost, HG
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (40) : 25893 - 25902
  • [4] Emerging role of DYRK family protein kinases as regulators of protein stability in cell cycle control
    Becker, Walter
    [J]. CELL CYCLE, 2012, 11 (18) : 3389 - 3394
  • [5] Exploring the Link between Germline and Somatic Genetic Alterations in Breast Carcinogenesis
    Bonifaci, Nuria
    Gorski, Bohdan
    Masojc, Bartlomiej
    Wokolorczyk, Dominika
    Jakubowska, Anna
    Debniak, Tadeusz
    Berenguer, Antoni
    Serra Musach, Jordi
    Brunet, Joan
    Dopazo, Joaquin
    Narod, Steven A.
    Lubinski, Jan
    Lazaro, Conxi
    Cybulski, Cezary
    Angel Pujana, Miguel
    [J]. PLOS ONE, 2010, 5 (11):
  • [6] Updating dual-specificity tyrosine-phosphorylation-regulated kinase 2 (DYRK2): molecular basis, functions and role in diseases
    Correa-Saez, Alejandro
    Jimenez-Izquierdo, Rafael
    Garrido-Rodriguez, Martin
    Morrugares, Rosario
    Munoz, Eduardo
    Calzado, Marco A.
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2020, 77 (23) : 4747 - 4763
  • [7] Patterns of somatic mutation in human cancer genomes
    Greenman, Christopher
    Stephens, Philip
    Smith, Raffaella
    Dalgliesh, Gillian L.
    Hunter, Christopher
    Bignell, Graham
    Davies, Helen
    Teague, Jon
    Butler, Adam
    Edkins, Sarah
    O'Meara, Sarah
    Vastrik, Imre
    Schmidt, Esther E.
    Avis, Tim
    Barthorpe, Syd
    Bhamra, Gurpreet
    Buck, Gemma
    Choudhury, Bhudipa
    Clements, Jody
    Cole, Jennifer
    Dicks, Ed
    Forbes, Simon
    Gray, Kris
    Halliday, Kelly
    Harrison, Rachel
    Hills, Katy
    Hinton, Jon
    Jenkinson, Andy
    Jones, David
    Menzies, Andy
    Mironenko, Tatiana
    Perry, Janet
    Raine, Keiran
    Richardson, Dave
    Shepherd, Rebecca
    Small, Alexandra
    Tofts, Calli
    Varian, Jennifer
    Webb, Tony
    West, Sofie
    Widaa, Sara
    Yates, Andy
    Cahill, Daniel P.
    Louis, David N.
    Goldstraw, Peter
    Nicholson, Andrew G.
    Brasseur, Francis
    Looijenga, Leendert
    Weber, Barbara L.
    Chiew, Yoke-Eng
    [J]. NATURE, 2007, 446 (7132) : 153 - 158
  • [8] Site-specific proteasome phosphorylation controls cell proliferation and tumorigenesis
    Guo, Xing
    Wang, Xiaorong
    Wang, Zhiping
    Banerjee, Sourav
    Yang, Jing
    Huang, Lan
    Dixon, Jack E.
    [J]. NATURE CELL BIOLOGY, 2016, 18 (02) : 202 - +
  • [9] Enforced dual-specificity tyrosine-regulated kinase 2 expression by adenovirus-mediated gene transfer inhibits tumor growth and metastasis of colorectal cancer
    Imaizumi, Yuta
    Yoshida, Saishu
    Kanegae, Yumi
    Eto, Ken
    Yoshida, Kiyotsugu
    [J]. CANCER SCIENCE, 2022, 113 (03) : 960 - 970
  • [10] Downregulation of dual-specificity tyrosine-regulated kinase 2 promotes tumor cell proliferation and invasion by enhancing cyclin-dependent kinase 14 expression in breast cancer
    Imawari, Yoshimi
    Mimoto, Rei
    Hirooka, Shinichi
    Morikawa, Toshiaki
    Takeyama, Hiroshi
    Yoshida, Kiyotsugu
    [J]. CANCER SCIENCE, 2018, 109 (02): : 363 - 372